Sharps Technology Receives Purchase Orders For 1M SecureGard Syringes For 2024 Delivery
Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies issues purchase orders for 1mL SecureGard ultra-low waste, smart safety syringes
First 100k unit shipment is scheduled for late July, with the balance to be shipped throughout Q3 and Q4 of this year
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class prefillable and disposable syringe products has received two purchase orders for a total of approximately 1 million SecureGard ultra-low waste smart safety syringes produced at Sharps' manufacturing facility in Hungary. The first 100k syringe shipment is scheduled for the third week of July, and subsequent deliveries will be made throughout the rest of 2024. Sharps is working to create a long-term, strategic partnership with the customer, a major Swiss-based global provider of cosmetic, dental, and ophthalmic injectable therapies. The initial 1mL SecureGard syringe orders are a first step in a collaboration that can leverage Sharps' innovative technology, portfolio of drug delivery solutions, and development expertise to support the customer's growing product offerings.